U.S. Launches SURPASS to Reshape Clinical Trials Through Simulation and Real-Time Analysis
Allowing trials to adapt as data accumulate and reducing the cost of repeatedly setting them up are central ideas behind a new U.S. research program. Whether this framework, spanning predictive models and community trial sites, can accelerate the evaluation of new drugs still needs to be demonstrated with reliable clinical evidence.